Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - FREE CASH FLOW
Free Cash Flow RARE - Ultragenyx Pharmaceutical Inc.
-422 M
LAST VALUE
10.51%
2 YEAR CAGR
-2.64%
5 YEAR CAGR
-24.59%
10 YEAR CAGR